Skip Navigation
 
 
 
 
Wilmer Eye Institute
 
Print This Page
Share this page: More
 

2. Decreasing the impact of glaucoma’s vision damage on the quality of life of those affected

Drs. Ramulu, Boland, and Jampel

The GCE’s common goal is to increase the quality of life of glaucoma patients at Wilmer and beyond. To that end, we have an active research program into how glaucoma impacts activities of daily living, such as reading, driving, and mobility. The outcomes will be recommendations about how to live more safely, especially avoiding falls and motor vehicle accidents. We collaborate with visual rehabilitation specialists to develop methods for better reading and walking in patients with advanced glaucoma. This research uses existing GCE patients, as well as population-based databases.

Initial collaborations with Wilmer Dana Center epidemiologists have shown that patients with early glaucoma are more likely to stop driving, that patients with moderately severe glaucoma walk more slowly and more often bump into objects, and that patients with advanced glaucoma read for shorter periods of time. Ongoing investigations study travel outside the home, measure physical activity, and have developed new tests to evaluate the ability to read books.

Based on present research results and anticipating findings in these areas, we propose to develop patient education materials to be used in our new patient care approach (priority area 6). This will raise awareness for both physicians and patients of quality of life issues and take important steps towards avoiding driving and walking-related injuries. The program will have costs for development of the teaching materials and for a nurse—counselor to work full time testing the methods objectively ($50,000 per year).

The GCE project will determine which visual rehabilitation approaches most effectively enable our patients to complete their life goals. Amazingly, not a single study has focused on rehabilitation efforts to decrease disability among glaucoma patients. We seek funding of $100,000 to support such research initiatives, to formalize protocols for rehabilitating glaucoma patients and to evaluate their outcomes in collaboration with the Wilmer Lions Vision Center as well as geriatric specialists at Bayview.

Important News

Dr. Derek Welsbie Receives RPB Career Development Award - 6/18/2013

Dr. Albert Jun Authors Study on Possible Breakthrough Treatment for Fuchs Dystrophy - 6/18/2013

Dr. Pradeep Ramulu's Research on Vision Loss and Balance  Published in JAMA Ophthalmology - 6/12/2013

Peter McDonnell Elected Board President of NAEVR/AEVR - 5/14/2013

Wilmer Researchers in the Spotlight - 4/17/2013

Wilmer Glaucoma Faculty Receive NIH Grant for Research on Falls - 4/15/2013

KKESH Research News, April 2013 - 4/15/2013

Implantable Telescope Lens to Treat Macular Degeneration Available at Wilmer - 3/21/2013

Dr. Hendrik Scholl to Direct Study on Stargardt Disease - 3/15/2013

Argus II Retinal Prosthesis Receives FDA Approval - 3/7/2013

Wilmer Opens New Location in Bethesda - 3/5/2013

Wilmer Professor Alfred Sommer Named Dan David Laureate - 2/15/2013

Wilmer Faculty Member Performs First Retinal Implant Surgery in Middle East - 2/8/2013

Wilmer Faculty Receive Honors Abroad - 2/6/2013

Wilmer Glaucoma Specialists on the Latest in Research and Patient Care - 1/16/2013

Dr. David Friedman's Research Links Vision Loss and Diabetes - 12/17/2012

Wilmer's Odenton Office Moves to a New Space - 12/5/2012

Wilmer Glaucoma Faculty Receive NIH Grant for Gene Research - 12/4/2012

Dr. Thorne Patient Honored for Fundraising Work - 12/3/2012

Dr. Boris Gramatikov Receives Research Award - 11/7/2012

Dr. Peter Campochiaro Honored by Macula Society - 11/6/2012

Dr. Robert Massof Honored by White House - 10/15/2012

Dr. Neil Bressler's Research Offers Hope to Those With AMD - 10/2/2012

 

 

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Maryland 410-955-5464
U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424

 

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer